Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Obstet Gynaecol ; 40(5): 591-601, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31478426

RESUMEN

Evidence-based guidelines on the management of pain associated with first-trimester medical abortion are lacking. Most published clinical trials have failed to report on this important aspect of the procedure. The aim of this comprehensive work was to provide clinical advice based on a comprehensive literature review, supplemented by the clinical experience of a group of European experts in case no evidence is available. Pain level ranged from 5 to 8 in 80% of studies where pain was measured on a 0-10 visual analogue scale; severe pain was reported by 20-80% of women. Pain assessment was rarely reported in studies. Pain treatment should be preventive and avoidance of unnecessary uterine contractions should be considered. Analgesic treatment should follow the WHO three-step ladder, starting with the use of NSAIDs and allowing for easily available back-up treatment with weak opioids.


Asunto(s)
Aborto Inducido/efectos adversos , Manejo del Dolor/métodos , Dimensión del Dolor/métodos , Abortivos Esteroideos/efectos adversos , Abortivos Esteroideos/farmacología , Aborto Inducido/métodos , Antiinflamatorios no Esteroideos/administración & dosificación , Consenso , Femenino , Humanos , Ibuprofeno/administración & dosificación , Mifepristona/efectos adversos , Mifepristona/farmacología , Misoprostol/efectos adversos , Misoprostol/farmacología , Embarazo , Primer Trimestre del Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA